The Impact of MiR-33a-5p Inhibition in Pro-Inflammatory Endothelial Cells
Diseases · 24.06.2023 · 11 (3) · 88
DOI: 10.3390/diseases11030088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases, online erschienen am 24.06.2023. Verfasst von Kun Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food, Nutrition, and Packaging Sciences, Clemson University, Clemson, SC 29634, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, United States Department of Agriculture, National Institute of Food and Agriculture, NIH/NIGMS SC BioCRAFT Pilot Project Award.
Abstract (Originalsprache)
Evidence suggests cholesterol accumulation in pro-inflammatory endothelial cells (EC) contributes to triggering atherogenesis and driving atherosclerosis progression. Therefore, inhibiting miR-33a-5p within inflamed endothelium may prevent and treat atherosclerosis by enhancing apoAI-mediated cholesterol efflux by upregulating ABCA1. However, it is not entirely elucidated whether inhibition of miR-33a-5p in pro-inflammatory EC is capable of increasing ABCA1-dependent cholesterol efflux. In our study, we initially transfected LPS-challenged, immortalized mouse aortic EC (iMAEC) with either pAntimiR33a5p plasmid DNA or the control plasmid, pScr. We detected significant increases in both ABCA1 protein expression and apoAI-mediated cholesterol efflux in iMAEC transfected with pAntimiR33a5p when compared to iMAEC transfected with pScr. We subsequently used polymersomes targeting inflamed endothelium to deliver either pAntimiR33a5p or pScr to cultured iMAEC and showed that the polymersomes were selective in targeting pro-inflammatory iMAEC. Moreover, when we exposed LPS-challenged iMAEC to these polymersomes, we observed a significant decrease in miR-33a-5p expression in iMAEC incubated with polymersomes containing pAntimR33a5p versus control iMAEC. We also detected non-significant increases in both ABCA1 protein and apoAI-mediated cholesterol in iMAEC exposed to polymersomes containing pAntimR33a5p when compared to control iMAEC. Based on our results, inhibiting miR-33a-5p in pro-inflammatory EC exhibits atheroprotective effects, and so precisely delivering anti-miR-33a-5p to these cells is a promising anti-atherogenic strategy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Food, Nutrition, and Packaging Sciences, Clemson University, Clemson, SC 29634, USA.
- Department of Chemical and Biomolecular Engineering, Clemson University, Clemson, SC 29634, USA.
- Department of Obstetrics & Gynecology, University of Washington, Seattle, WA 98109, USA.
- Department of Bioengineering, Clemson University, Clemson, SC 29634, USA.
- Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30322, USA.
ORCID-Profile: Lucia Vojtech, Jessica Larsen
Förderung
- NIH HHS
- United States Department of Agriculture, National Institute of Food and Agriculture
- NIH/NIGMS SC BioCRAFT Pilot Project Award
- CU FELLOWS R-Initiatives
Zitieren
APA
Huang, K., Pitman, M., Oladosu, O., Echesabal-Chen, J., Vojtech, L., Esobi, I., Larsen, J., Jo, H., & Stamatikos, A. (2023). The Impact of MiR-33a-5p Inhibition in Pro-Inflammatory Endothelial Cells. Diseases, 11(3), 88. https://doi.org/10.3390/diseases11030088
Vancouver
Huang K, Pitman M, Oladosu O, Echesabal-Chen J, Vojtech L, Esobi I, et al. The Impact of MiR-33a-5p Inhibition in Pro-Inflammatory Endothelial Cells. Diseases. 2023;11(3):88. doi:10.3390/diseases11030088
BibTeX
@article{Huang2023,
author = {Huang, Kun and Pitman, Mark and Oladosu, Olanrewaju and Echesabal-Chen, Jing and Vojtech, Lucia and Esobi, Ikechukwu and Larsen, Jessica and Jo, Hanjoong and Stamatikos, Alexis},
title = {The Impact of MiR-33a-5p Inhibition in Pro-Inflammatory Endothelial Cells},
journal = {Diseases},
year = {2023},
volume = {11},
number = {3},
pages = {88},
doi = {10.3390/diseases11030088}
}
EUVIMED